Cargando…

BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model

Standard imaging cannot reliably predict the nature of renal tumors. Among malignant renal tumors, clear cell renal cell carcinoma (ccRCC) is the most common histological subtype, in which the vascular endothelial growth factor 2 (VEGFR-2) is highly expressed in the vascular endothelium. BR55, a con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Courcier, Jean, Leguerney, Ingrid, Benatsou, Baya, Pochon, Sibylle, Tardy, Isabelle, Albiges, Laurence, Cournède, Paul-Henry, De La Taille, Alexandre, Lassau, Nathalie, Ingels, Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671137/ https://www.ncbi.nlm.nih.gov/pubmed/38003400 http://dx.doi.org/10.3390/ijms242216211

Ejemplares similares

Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles
por: Ingels, Alexandre, et al.
Publicado: (2020)

Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management
por: Courcier, Jean, et al.
Publicado: (2020)

Prediction of Early Response to Immunotherapy: DCE-US as a New Biomarker
por: Naccache, Raphael, et al.
Publicado: (2022)

Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response
por: Zafarnia, Sara, et al.
Publicado: (2017)

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs
por: Decazes, Pierre, et al.
Publicado: (2023)

Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma
por: Leguerney, Ingrid, et al.
Publicado: (2017)

Surgical and oncological management of renal medullary carcinoma in a young patient: a case report
por: Courcier, Jean, et al.
Publicado: (2023)

Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
por: Jin, Fa, et al.
Publicado: (2019)

Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model
por: He, Shuning, et al.
Publicado: (2012)

RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs
por: Beuselinck, B, et al.
Publicado: (2015)

Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts
por: Chen, Chun-Hau, et al.
Publicado: (2019)

Quantitative fluorescent profiling of VEGFRs reveals tumor cell and endothelial cell heterogeneity in breast cancer xenografts
por: Imoukhuede, Princess I, et al.
Publicado: (2014)

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases
por: Loizzi, Vera, et al.
Publicado: (2021)

Characterising the pulmonary response to prone positioning. Comment on Br J Anaesth 2021; 126: 48-55
por: Chad, Thomas
Publicado: (2021)

VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma
por: Lkhagvadorj, Sayamaa, et al.
Publicado: (2014)

Endothelial Ca(2+) oscillations reflect VEGFR signaling-regulated angiogenic capacity in vivo
por: Yokota, Yasuhiro, et al.
Publicado: (2015)

Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma
por: An, Hyo Jung, et al.
Publicado: (2019)

Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts
por: Bozec, A, et al.
Publicado: (2007)

Molecularly Targeted Therapy of Human Hepatocellular Carcinoma Xenografts with Radio-iodinated Anti-VEGFR2 Murine-Human Chimeric Fab
por: Huang, Jianfei, et al.
Publicado: (2015)

Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts
por: Park, Mi Sun, et al.
Publicado: (2014)

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth
por: Stagg, Brian C., et al.
Publicado: (2014)

Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model
por: Zalles, Michelle, et al.
Publicado: (2019)

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
por: Zalles, Michelle, et al.
Publicado: (2020)

Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer
por: Belkacemi, Yazid, et al.
Publicado: (2023)

Perceived vulnerability to disease: adaptation and validation of the PVD-br
por: Do Bú, Emerson Araújo, et al.
Publicado: (2021)

Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
por: Marchioni, Michele, et al.
Publicado: (2022)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2
por: Navis, Anna C., et al.
Publicado: (2013)

PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI–Resistant Metastatic Clear Cell Renal Cell Carcinoma
por: Jeong, Se Un, et al.
Publicado: (2023)

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis
por: Zhou, Libin, et al.
Publicado: (2019)

Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer
por: Diamant, Elliott, et al.
Publicado: (2022)

Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. Cancers 2022, 14, 3797
por: Diamant, Elliott, et al.
Publicado: (2022)

Phase Equilibria in Ternary System CsBr-AgBr-InBr(3)
por: Kamilov, Rustam K., et al.
Publicado: (2023)

Mirrors and Reflections
por: Borovik, Alexandre V, et al.
Publicado: (2010)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
por: Dieterich, Lothar C., et al.
Publicado: (2017)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
por: Yamamoto, Yuji, et al.
Publicado: (2014)

RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib
por: Bradford, James R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_opjep9jp2esldrfq741hg6fl40